PreviPharma GmbH
Mannheim, Germany previpharma.com
From their website, Nov 2026
Work here? Claim this listing
- GLP
- GMP
About
PreviPharma GmbH is a research and manufacturing partner for the plasma fractionation industry. It supports projects across the R&D supply chain, from early research and analytical development to GMP-compliant manufacturing and life-cycle management. The company is based in Mannheim, Germany.
Services
Research services
Supports projects across the plasma fractionation R&D value chain, from early-stage research and clinical study guidance through production process support and life-cycle management.
Strategic research support
Provides guidance for target validation, mode of action analysis, and candidate selection, with close integration to in-vivo programs.
Process development and optimization
Develops and optimizes plasma protein processes from source materials through product formation, including chromatographic, filtration, fractionation, and formulation steps.
Analytical method development and implementation
Develops, qualifies, and implements analytical methods, including matrix evaluation, feasibility assessment, method optimization, bridging studies, and preparation for regulatory validation.
Preclinical capabilities and expertise
Provides in-vitro and in-vivo research support, including screening, mechanistic studies, translational research, and regulated preclinical development.
ADME, DMPK & toxicology
Manufacturing of plasma proteins
Produces research-grade, GLP-tox-compliant, and GMP-compliant plasma protein material, with up- and downscaling and contract manufacturing support.
CDMO: development & manufacturing
End-to-end quality
Maintains integrated quality systems, SOPs, documentation, traceability, audits, and data-integrity processes across research, development, and manufacturing work.
Process Development & Optimization
Supports process development and optimization for existing and novel proteins, including formulation and novel fractionation technologies.
Preclinical & Clinical Capabilities & Expertise
Offers in-vitro analytics, in-vivo studies, clinical study planning and guidance, and pathogen safety studies.
ADME, DMPK & toxicology
Development & Execution of Analytical Methods
Designs, validates, and executes analytical methods, including advanced diagnostics.
- What to send
- Patient samples and data
Capabilities
- Assays and studies
- Process development · Toxicology · Cell-based assays · Biochemical assays · In-vitro analytics · In-vivo studies · Clinical studies · Pathogen safety studies · Diagnostic studies · Method development · Validation · Purity assessment
9 more
Identity confirmation · Impurity quantification · Aggregation analysis · Stability profiling · Fragmentation studies · Target validation · Mode of Action (MoA) analysis · Advanced testing · Advanced diagnostics - Scale and capacity
- Up to 30 liters · Up to 100 liters · Batch chromatography 1 mL to 10 L column volume · Filtration areas from 0.0073 m² to 0.1 m² · Filter presses frame width 10–30 cm · Up to 300 liters · 100 L · Future expansion projected up to 2,000 liters
- Therapeutic areas
- Plasma fractionation · Plasma protein therapies
Instruments and platforms
- Nanofiltration (NF)
- PCC
- SMB
- TFF
Modalities and species
- Modalities
- Plasma proteins · Plasma-derived proteins · Existing proteins · Novel proteins · Plasma fractionation products
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing
GLPSelf-reported
Scope: material
Industries served
- Plasma fractionation industry
- Pharmaceutical
Company
- Type
- CRDMO
Locations
- Based in
- Mannheim, Germany
- Sites
- Mannheim, Germany
- Serves
- international
Contacts
- General enquiry
- info@previpharma.com on their site
- Phone
- +49 (0) 621 72 847 848
Similar labs
Work here? Claim this listing